1. Home
  2. TCPC vs NNNN Comparison

TCPC vs NNNN Comparison

Compare TCPC & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock TCP Capital Corp.

TCPC

BlackRock TCP Capital Corp.

N/A

Current Price

$4.00

Market Cap

346.5M

Sector

Finance

ML Signal

N/A

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$5.60

Market Cap

340.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TCPC
NNNN
Founded
2006
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
346.5M
340.2M
IPO Year
2006
2023

Fundamental Metrics

Financial Performance
Metric
TCPC
NNNN
Price
$4.00
$5.60
Analyst Decision
Sell
Analyst Count
2
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
632.9K
208.6K
Earning Date
05-07-2026
04-07-2026
Dividend Yield
18.23%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$3.08
$6.13
52 Week High
$6.79
$51.33

Technical Indicators

Market Signals
Indicator
TCPC
NNNN
Relative Strength Index (RSI) 40.71 23.37
Support Level $3.67 N/A
Resistance Level $3.98 $12.10
Average True Range (ATR) 0.08 0.50
MACD -0.05 0.01
Stochastic Oscillator 15.96 11.09

Price Performance

Historical Comparison
TCPC
NNNN

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve its investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights, or direct equity investments.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: